On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Direktoratet for medisinske produkter

InstitutionResearch output, impact & collaborations

Direktoratet for medisinske produkter is a institution indexed in ScholarIQ from OpenAlex.

What is known about Direktoratet for medisinske produkter?

ScholarIQrecord summary

Direktoratet for medisinske produkter is a research organisation in Oslo, NO. OpenAlex records 550 works and 15,955 citations for it. 158 researchers list it as their most recent affiliation.

How many works does Direktoratet for medisinske produkter have?

ScholarIQindexed works

Direktoratet for medisinske produkter has 550 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Direktoratet for medisinske produkter →

How many citations does Direktoratet for medisinske produkter have?

ScholarIQcitation count

Direktoratet for medisinske produkter has 15,955 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Direktoratet for medisinske produkter →

How many researchers are at Direktoratet for medisinske produkter?

ScholarIQresearcher count

Direktoratet for medisinske produkter has 158 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Direktoratet for medisinske produkter?

ScholarIQavg h-index

Direktoratet for medisinske produkter has an average h-index of 17 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Direktoratet for medisinske produkter?

ScholarIQror

The ROR for Direktoratet for medisinske produkter is on the source record.

Open the ROR →

What is the OpenAlex record for Direktoratet for medisinske produkter?

ScholarIQopenalex

The OpenAlex for Direktoratet for medisinske produkter is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind Direktoratet for medisinske produkter?

ScholarIQtop researchers by citations

Anja Schiel · Health Systems, Economic Evaluations, Quality of Life

45 works1,062 citations

What are the most-cited papers on Direktoratet for medisinske produkter?

ScholarIQmost cited works

Induction of Thyroid Hormone-Degrading Deiodinase in Cardiac Hypertrophy and Failure

Frank W. J. S. Wassen, Anja Schiel, George G. J. M. Kuiper, Ellen Kaptein, Onno Bakker, Theo J. Visser, Warner S. Simonides

Endocrinology. 2002138 CitationsOPEN ACCESS

Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure

Henk P.J. Buermans, Everaldo M. Redout, Anja Schiel, René J.P. Musters, Marian J. Zuidwijk, Paul P. Eijk, Cornelis van Hardeveld, Soemini Kasanmoentalib, Frans C. Visser, Bauke Ylstra, Warner S. Simonides

Physiological Genomics. 2005136 CitationsOPEN ACCESS

Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials

Olivier Collignon, Christian Gärtner, Anna‐Bettina Haidich, Robert Hemmings, Benjamin Hofner, Frank Pétavy, Martin Posch, Khadija Rantell, Kit C. B. Roes, Anja Schiel

Clinical Pharmacology & Therapeutics. 202091 Citations

The use of external controls: To what extent can it currently be recommended?

Hans Ulrich Burger, Christoph Gerlinger, Chris Harbron, Armin Koch, Martin Posch, Justine Rochon, Anja Schiel

Pharmaceutical Statistics. 202188 CitationsOPEN ACCESS

Intrauterine Exposure to Maternal Atherosclerotic Risk Factors Increases the Susceptibility to Atherosclerosis in Adult Life

Fanneke E. Alkemade, Adriana C. Gittenberger–de Groot, Anja Schiel, J. Conny VanMunsteren, Bianca Hogers, Leontien S. J. van Vliet, Robert E. Poelmann, Louis M. Havekes, Ko Willems van Dijk, Marco C. DeRuiter

Arteriosclerosis Thrombosis and Vascular Biology. 200772 CitationsOPEN ACCESS

How much of the research on Direktoratet for medisinske produkter is open access?

ScholarIQopen access share

73%OPEN ACCESS

Gold

Green

27%

Hybrid

Bronze

36%

Closed

27%